Ledger.Open graph →
SEC Form D · filed September 28, 2016

Eleven Biotherapeutics, Inc

Offering
$13.5M
Sold
$13.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Daniel S. Lynch · Cambridge, MADirectorAbbie C. Celniker, Ph.D · Cambridge, MADirectorJane V. Henderson · Cambridge, MADirectorPaul G. Chaney · Cambridge, MADirectorWendy L. Dixon · Cambridge, MADirectorStephen V. Hurly · Cambridge, MAExec · DirectorLeslie V. Dan · Cambridge, MADirectorGavin L. James · PASADENA, CADirectorSteven E. Brox · Draper, UTDirectorJohn C. Mccabe · Cambridge, MAExecJay S. Duker · Cambridge, MADirectorBarry J. Gertz · Cambridge, MADirectorArthur P. Decillis · Cambridge, MAExecSteve Adler · Santa Monica, CADirectorMichael B. Zelouf · PASADENA, CADirectorDavid E. Flynn · Draper, UTDirectorLohra L. Miller · Draper, UTDirectorJane V. Henderson · Cambridge, MADirectorStephen V. Hurly · Cambridge, MAExec · DirectorJohn C. Mccabe · Cambridge, MAExecJay S. Duker · Cambridge, MADirectorBarry J. Gertz · Cambridge, MADirectorLeslie V. Dan · Cambridge, MADirectorArthur P. Decillis · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗